IL-19 promotes proliferation and migration directly while secondarily, it provides a microenvironment for tumor development, with high IL-19 expression levels being associated with a poor clinical outcome for breast cancer patients [41-42]. The gene discussed is IL19; the disease is breast carcinoma.